A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

PHASE3CompletedINTERVENTIONAL
Enrollment

732

Participants

Timeline

Start Date

November 16, 2015

Primary Completion Date

February 21, 2018

Study Completion Date

February 21, 2018

Conditions
Acne Vulgaris
Interventions
DRUG

CB-03-01 cream, 1%

CB-03-01 (cortexolone 17α-propionate) is a steroidal antiandrogen that is being developed as a 1% cream for the topical treatment of acne vulgaris.

DRUG

Vehicle cream

Vehicle cream manufactured to mimic look and feel of CB-03-01 but without the active ingredient cortexolone 17α-propionate.

Trial Locations (52)

1000

Site 3523, Sofia

1404

Site 3525, Sofia

1407

3520, Sofia

Site 3524, Sofia

1431

Site 3519, Sofia

1618

Site 3526, Sofia

2100

Site 9925, Zugdidi

4000

Site 3521, Plovdiv

4600

Site 9924, Kutaisi

6010

Site 9923, Batumi

8137

Site 8137, Belgrade

9010

Site 3522, Varna

10075

Sadick Research Group, LLC, New York

10155

Skin Specialty Dermatology, New York

11050

Site 8138, Belgrade

21000

Site 8136, Novi Sad

21030

Maryland Laser Skin and Vein Institute, Hunt Valley

33781

Belleair Research Center, Pinellas Park

60005

Arlington Dermatology, Arlington Heights

66215

Kansas City Dermatology, PA, Overland Park

72916

Johnson Dermatology, Fort Smith

78218

Texas Dermatology and Laser Specialists, San Antonio

78229

Progressive Clinical Research, PA, San Antonio

85255

Clear dermatology & Aesthetic Center, Scottsdale

95819

Center for Dermatology and Laser Surgery, Sacramento

200642

Site 4032, Craiova

550245

Site 4030, Sibiu

700381

Site 4037, Iași

02919

Clinical Partners, LLC, Johnston

0145

Site 9921, Tbilisi

0177

Site 9920, Tbilisi

0186

Site 9922, Tbilisi

85-863

4819, Bydgoszcz

15-794

Site 4814, Częstochowa

42-217

Site 4822, Częstochowa

40-611

4815, Katowice

Site 4815, Krakow

62-069

Site 4811, Katowice

30-002

Site 4821, Krakow

70-332

Site 4813, Krakow

91-334

Site 4820, Lodz

86-031

Site 4823, Osielsko

61-113

Site 4816, Rzeszów

51-685

Site 4812, Szczecin

02-106

Site 4818, Warsaw

020125

Site 4033, Sector 2

Site 4034, Sector 2

030303

Site 4031, Sector 3

062272

Site 4029, Sector 6

Unknown

Site 4028, Târgovişte

010825

Site 4036, Bucharest

011025

Site 4035, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cassiopea SpA

INDUSTRY

NCT02608476 - A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) | Biotech Hunter | Biotech Hunter